Senti Biosciences Inc [NASDAQ: SNTI] gained 362.96% on the last trading session, reaching $10.00 price per share at the time.
If compared to the average trading volume of 17.91K shares, SNTI reached a trading volume of 129118646 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about Senti Biosciences Inc [SNTI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SNTI shares is $10.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SNTI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for Senti Biosciences Inc shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on October 07, 2022.
The Average True Range (ATR) for Senti Biosciences Inc is set at 1.20 The Price to Book ratio for the last quarter was 2.87, with the Price to Cash per share for the same quarter was set at 2.26.
Trading performance analysis for SNTI stock
Senti Biosciences Inc [SNTI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 360.70. With this latest performance, SNTI shares gained by 360.83% in over the last four-week period, additionally plugging by 233.78% over the last 6 months – not to mention a rise of 132.50% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SNTI stock in for the last two-week period is set at 95.34, with the RSI for the last a single of trading hit 97.40, and the three-weeks RSI is set at 92.72 for Senti Biosciences Inc [SNTI]. The present Moving Average for the last 50 days of trading for this stock 2.39, while it was recorded at 3.72 for the last single week of trading, and 2.98 for the last 200 days.
Senti Biosciences Inc [SNTI]: A deeper dive into fundamental analysis
Senti Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.92 and a Current Ratio set at 1.92.
Senti Biosciences Inc [SNTI]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SNTI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Senti Biosciences Inc go to 17.99%.
An analysis of Institutional ownership at Senti Biosciences Inc [SNTI]
There are presently around $23.33%, or 29.53%% of SNTI stock, in the hands of institutional investors. The top three institutional holders of SNTI stocks are: NEA MANAGEMENT COMPANY, LLC with ownership of 4.43 million shares, which is approximately 9.6834%. 8VC GP I, LLC, holding 2.54 million shares of the stock with an approximate value of $$7.0 million in SNTI stocks shares; and 8VC GP I, LLC, currently with $$0.44 million in SNTI stock with ownership which is approximately 3.4693%.
